Wintest
6721
Osaka Yuka Industry
4124
D. Western Therapeutics Institute
4576
Asiro
7378
Hamee
3134
(FY)Sep 30, 2023 | (FY)Sep 30, 2022 | (FY)Sep 30, 2021 | (FY)Sep 30, 2020 | (FY)Sep 30, 2019 | |
---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||
Cash from operating activities | 70.16%982.9M | 48.48%577.64M | -21.11%389.04M | 12.23%493.13M | 439.38M |
Net profit before non-cash adjustment | 28.29%701.09M | 17.77%546.49M | 53.10%464.02M | -9.22%303.08M | --333.86M |
Total adjustment of non-cash items | 6.64%124.91M | 23.22%117.14M | 19.86%95.06M | 43.93%79.31M | --55.1M |
-Depreciation and amortization | 1.36%115.06M | 42.80%113.52M | 5.12%79.5M | 53.96%75.63M | --49.12M |
-Disposal profit | --0 | ---95K | ---- | 244.98%361K | ---249K |
-Remuneration paid in stock | --3.34M | --0 | ---- | ---- | ---- |
-Other non-cash items | 75.72%6.51M | -76.18%3.71M | 368.51%15.56M | -46.69%3.32M | --6.23M |
Changes in working capital | 282.47%156.89M | 49.44%-85.98M | -253.55%-170.05M | 119.62%110.74M | --50.42M |
-Change in receivables | 108.99%12.75M | -17.95%-141.84M | -559.96%-120.26M | 144.22%26.15M | ---59.13M |
-Change in inventory | -53.08%-45.99M | ---30.04M | ---- | ---- | ---- |
-Change in payables | -111.91%-5.44M | 504.19%45.66M | ---11.3M | ---- | ---- |
-Change in accrued expense | 6,518.32%102.58M | 16.28%1.55M | -42.44%1.33M | 104.97%2.32M | ---46.63M |
-Provision for loans, leases and other losses | 21.48%61.57M | 14.41%50.68M | -10.72%44.3M | 44.22%49.62M | --34.4M |
-Changes in other current assets | -2.69%14.67M | 5.34%15.08M | 44.06%14.32M | 257.06%9.94M | ---6.33M |
-Changes in other current liabilities | 161.84%16.74M | 72.50%-27.07M | -533.23%-98.44M | -82.26%22.72M | --128.11M |
Dividends paid (cash flow from operating activities) | |||||
Dividends received (cash flow from operating activities) | |||||
Interest paid (cash flow from operating activities) | -62.39%-6.04M | -94.56%-3.72M | 42.50%-1.91M | 8.10%-3.33M | -3.62M |
Interest received (cash flow from operating activities) | -69.23%4K | 160.00%13K | 66.67%5K | -70.00%3K | 10K |
Tax refund paid | -26.68%-253.93M | -67.60%-200.46M | 20.73%-119.6M | -18.46%-150.89M | -127.37M |
Other operating cash inflow (outflow) | 0 | 0.00%-1K | 0.00%-1K | -1K | 0 |
Operating cash flow | 93.57%722.94M | 39.60%373.48M | -21.07%267.53M | 9.90%338.92M | --308.4M |
Investing cash flow | |||||
Net PPE purchase and sale | -92.54%-6.01M | 71.41%-3.12M | 42.30%-10.92M | 67.89%-18.93M | ---58.95M |
Net intangibles purchase and sale | ---11.43M | --0 | ---- | ---- | ---- |
Net business purchase and sale | --0 | -892.01%-347.21M | 85.89%-35M | ---248.07M | ---- |
Net investment product transactions | -63,430.13%-151.36M | --239K | ---- | ---- | ---- |
Repayment of advance payments to other parties and cash income from loans | ---- | --10.33M | ---- | ---- | ---- |
Net changes in other investments | -109.27%-441K | 181.74%4.76M | -128.57%-5.82M | 77.23%-2.55M | ---11.18M |
Investing cash flow | 49.48%-169.25M | -547.51%-335M | 80.81%-51.74M | -284.37%-269.55M | ---70.13M |
Financing cash flow | |||||
Net issuance payments of debt | -65.90%95.33M | 400.02%279.6M | -212.09%-93.19M | 148.20%83.14M | ---172.48M |
Net common stock issuance | 46.79%-215.6M | -367.85%-405.17M | 328.43%151.27M | --35.31M | ---- |
Issuance fees | ---- | ---- | ---13.66M | ---- | ---- |
Cash dividends paid | 8.64%-86.2M | ---94.35M | ---- | ---- | ---42M |
Net other fund-raising expenses | ---- | 404,500.00%8.09M | ---2K | ---- | ---- |
Financing cash flow | 2.53%-206.47M | -576.96%-211.84M | -62.50%44.41M | 155.22%118.45M | ---214.48M |
Net cash flow | |||||
Beginning cash position | -20.49%672.86M | 44.40%846.22M | 47.14%586.02M | 6.31%398.28M | --374.65M |
Current changes in cash | 300.29%347.23M | -166.62%-173.36M | 38.54%260.2M | 689.27%187.82M | --23.8M |
Effect of exchange rate changes | ---- | ---- | ---- | 48.82%-87K | ---170K |
Cash adjustments other than cash changes | ---- | ---- | ---- | --1K | ---- |
End cash Position | 51.60%1.02B | -20.49%672.86M | 44.40%846.22M | 47.14%586.02M | --398.28M |
Free cash flow | 90.49%705.49M | 44.33%370.36M | -19.81%256.61M | 28.28%320M | --249.46M |
Currency Unit | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |